Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical"
StartUps
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
Business
– Some of the company’s Israeli shareholders having been cashing in on the share’s record price. – David Reis CEO Stratasys – The share...
Business
– Dan Propper, Chairman of the Israeli Osem Group of companies has sold the last of his shares to Swiss company Nestlé. The...
Business
– The network security company’s main patents are about to expire. – Check Point’s founder, chairman and CEO Gil Shwed – / By Shmulik Shelach...
Business
– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...
IPOs
– The medical devices company plans to raise the money at a company valuation of $500 million by February. – – Sources inform ”Globes”...
Blogs
– Israel is a tiny country – a beacon of light in a vast region of darkness. Inside the country, every Israeli seems...
StartUps
– Mooly Eden: Start-ups are fine, but we must attract the multinationals. – – “There is stigma over the tax breaks in the Law...
Business
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
Science
The Laquinimod-treated patients accumulated significantly less brain tissue damage caused by neurodegeneration, compared to placebo in MRI analyses.